As of November 2013, Ross Stores (ROST) operated 1,285 off-price retail stores offering various apparel, accessories, footwear, and home furnishings items under the names Ross and dd�� DISCOUNTS. Both of these chains primarily target 25 to 54 year-old value-conscious men and women in middle to moderate income households. Ross stores, the company�� primary name, average 29,300 square feet of selling space and are located in 33 states, as well as the District of Columbia and Guam. dd�� DISCOUNTS store average 23,800 square feet in 10 states. Almost all of the stores currently occupy leased facilities and are in neighborhood shopping centers. The stores are primarily located in heavily populated urban and suburban areas.
Ross Stores believes that it maintains a large competitive advantage by offering a varied assortment of quality brand name and fashion merchandise, with prices 20% to 60% lower than most department and specialty stores, all while being in an easy-to-shop environment. The vendors that company deals with are never ending. Ross Stores currently deals with more than 7,900 vendors and manufacturers. They are able to offer their extremely low prices by taking advantage of supply and demand imbalances, and making their purchases later in the buying cycle than most major retailers. Many purchases of cancellations and overruns are purchased, providing perfect opportunity. The majority of orders exclude promotional and markdown allowances, as well as return privileges. Again, more reasons as to why buyers are able to obtain significant discounts on the current-season purchases.
Top Medical Stocks To Own Right Now: Potash Corporation of Saskatchewan Inc.(POT)
Potash Corporation of Saskatchewan Inc. produces and sells fertilizers and related industrial and feed products primarily in the United States and Canada. The company mines and produces potash, which is used as fertilizer. It also offers solid and liquid phosphate fertilizers; animal feed supplements; and industrial acids that are used in food products and industrial processes. In addition, the company produces nitrogen fertilizers, as well as nitrogen feed and industrial products, including ammonia, urea, nitrogen solutions, ammonium nitrate, and nitric acid. Further, it holds the right to mine 785,759 acres of land in Saskatchewan; and 58,263 acres of land in New Brunswick in Canada. The company sells its fertilizers primarily to retailers, dealers, co-operatives, distributors, and other fertilizer producers; industrial products primarily to chemical product manufacturers; and purified phosphoric acid directly to consumers of the product. Potash Corporation was founded i n 1953 and is based in Saskatoon, Canada.
Advisors' Opinion:- [By Cameron Swinehart]
A diversified agriculture ETF with holdings in a variety of the largest agribusiness companies globally. Holdings include Bunge (BG), Archer Daniel Midland (AMD), PotashCorp (POT) and Deere (DE).
- [By Jim Jubak]
Exactly what was going on with Potash of Saskatchewan's (POT) second quarter earnings on July 25?
On the one hand, the company missed the consensus Wall Street forecast by 7 cents a share and lowered its guidance for the third quarter to 45 cents to 60 cents (versus the Wall Street projection of 74 cents) and for the full 2013 year to $2.45 to $2.70 from the previous guidance of $2.75 to $3.25 a share.
Best Low Price Stocks To Own For 2014: Raptor Pharmaceutical Corp.(RPTP)
Raptor Pharmaceuticals Corp. operates as a biotechnology company in the United States. The company is dedicated to speeding the delivery of new treatment options to patients by working to improve existing therapeutics through the application of highly specialized drug targeting platforms and formulation expertise. Its clinical stage development products include DR Cysteamine, which is in phase IIb for the treatment of cystinosis; phase IIa for the non-alcoholic steatohepatitis; and phase II for the treatment of Huntington?s disease. Raptor?s clinical-stage products also include Convivia that is in Phase IIa stage for the potential management of acetaldehyde toxicity due to alcohol consumption; and Tezampanel and NGX 426, which completed phase I stage for the treatment of migraine and pain. Its preclinical product candidates comprise HepTide for the treatment of Hepatocellular Carcinoma and Hepatitis; WntTide for the treatment of breast cancer; NeuroTrans for the treatmen t of neurodegenerative diseases; and Tezampanel and NGX 426 for the treatment of Thrombosis and Spasticity Disorder. Raptor Pharmaceuticals Corp. is headquartered in Novato, California.
Advisors' Opinion:- [By Sean Williams]
This week saw two new drugs approved by the FDA: Raptor Pharmaceuticals' (NASDAQ: RPTP ) Procysbi and Merck's (NYSE: MRK ) Liptruzet.
- [By Roberto Pedone]
One biotechnology player that's starting to trend within range of triggering a big breakout trade is Raptor Pharmaceuticals (RPTP), which has a pipeline that includes both candidates from its proprietary drug targeting platforms and in-licensed and acquired product candidates. This stock is in play with the bulls so far in 2013, with shares up sharply by 151%.
>>5 Hated Earnings Stocks You Should Love
If you take a look at the chart for Raptor Pharmaceuticals, you'll notice that stock has been uptrending strong for the last six months, with shares soaring higher from its low of $5.50 to its recent high of $15.29 a share. During that uptrend, shares of RPTP have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of RPTP within range of triggering a big breakout trade.
Traders should now look for long-biased trades in RPTP if it manages to break out above some near-term overhead resistance levels at $14.99 a share to its 52-week high at $15.29 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average volume of 844,332 shares. If that breakout triggers soon, then RPTP will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $18 to $20 a share, or even north of $20 a share.
Traders can look to buy RPTP off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $13.69 a share or at $13 a share. One can also buy RPTP off strength once it takes out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
- [By Jake L'Ecuyer]
Raptor Pharmaceuticals (NASDAQ: RPTP) was down, falling 20.45 percent to $11.77 after the company reported Q4 results. Raptor Pharmaceutical posted a Q4 loss of $0.20 per share, versus the projected loss of $0.16 per share.
- [By Jake L'Ecuyer]
Equities Trading UP
Raptor Pharmaceuticals (NASDAQ: RPTP) shot up 16.62 percent to $17.40 after the company announced positive clinical results with RP103 in Huntington's disease Phase 2/3 trial.
Best Low Price Stocks To Own For 2014: Gladstone Commercial Corporation(GOOD)
Gladstone Commercial Corporation operates as a real estate investment trust (REIT) in the United States. It engages in investing in and owning net leased industrial and commercial real properties, and making long-term industrial and commercial mortgage loans. The company leases its real estate properties to small businesses, as well as to large public companies. As of December 31, 2009, it owned 64 properties, and held 1 mortgage loan. The company qualifies as a REIT under the Internal Revenue Code of 1986. As a REIT, it would not be subject to federal tax to the extent that it distributes at least 90% of its taxable income to its shareholders. The company was founded in 2003 and is based in McLean, Virginia.
Advisors' Opinion:- [By GURUFOCUS]
Gladstone Commercial Corporation (GOOD) operates as a real estate investment trust (REIT) in the United States.Yield: 7.9%
Main Street Capital Corporation (MAIN) is a business development company specializing in long- term equity, equity related, and debt investments in small and lower middle market companies. Yield: 6.3%
Best Low Price Stocks To Own For 2014: Tile Shop Holdings Inc (TTS)
Tile Shop Holdings, Inc., incorporated on June 21, 2012, is a specialty retailer of manufactured and natural stone tiles, setting and maintenance materials, and related accessories in the United States. The Company sells over 4,500 products from around the world, including ceramic, porcelain, glass, and stainless steel manufactured tiles and, marble, granite, quartz, sandstone, travertine, slate, and onyx natural tiles. It purchases its tile products and accessories directly from producers. The Company manufactures its own setting and maintenance materials, such as thinset, grout, and sealers under its brand name. The Company operates 70 stores in 22 states, with an average size of 23,000 square feet. It also sells its products on its Website. In January 2014 Tile Shop Holdings Inc launched its first retail store in Oklahoma City.
The Company offers a complete assortment of tile products, generally sourced directly from producers, including ceramic, porcelain, glass, and stainless steel manufactured tiles, and marble, granite, quartz, sandstone, travertine, slate, and onyx natural tiles. The Company also offers a range of setting and maintenance materials, such as thinset, grout and sealers, and accessories, including installation tools, shower and bath caddies, drains, and similar products.
The Company competes with Home Depot, Tile America, World of Tile, Century Tile, and Floor and Decor, Dal-Tile and Florida Tile.
Advisors' Opinion:- [By Demitrios Kalogeropoulos]
The Tile Shop's (NASDAQ: TTS ) shares fell 11% yesterday despite no news coming from the company. Instead, investors were spooked by a big profit warning from a seemingly unrelated retailer: Lumber Liquidators (NYSE: LL ) .�
No comments:
Post a Comment